Arena Pharmaceuticals - Stock Price History | ARNA

Historical daily share price chart and data for Arena Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Arena Pharmaceuticals as of May 22, 2020 is 58.91.
  • The all-time high Arena Pharmaceuticals stock closing price was 462.50 on August 31, 2000.
  • The Arena Pharmaceuticals 52-week high stock price is 64.48, which is 9.5% above the current share price.
  • The Arena Pharmaceuticals 52-week low stock price is 32.95, which is 44.1% below the current share price.
  • The average Arena Pharmaceuticals stock price for the last 52 weeks is 50.35.
Arena Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 50.3058 40.2200 63.3300 39.5400 45.4200 16.61%
2018 40.4410 36.2100 49.6300 30.8900 38.9500 14.66%
2017 20.0076 14.7000 34.6600 11.5000 33.9700 139.23%
2016 16.5036 18.3000 21.5000 13.5000 14.2000 -25.26%
2015 35.8980 35.9000 60.5000 17.0000 19.0000 -45.24%
2014 53.4490 58.7000 77.2000 33.7000 34.7000 -40.68%
2013 71.6921 90.1000 108.1000 40.8000 58.5000 -35.14%
2012 62.7528 19.2000 118.1000 15.6000 90.2000 382.35%
2011 15.0441 17.7000 21.9000 12.3000 18.7000 8.72%
2010 33.1954 35.3000 79.5000 12.7000 17.2000 -51.55%
2009 40.8730 42.5000 71.5000 23.2000 35.5000 -14.87%
2008 55.5846 76.7000 84.8000 29.3000 41.7000 -46.74%
2007 116.7563 127.2000 145.7000 78.3000 78.3000 -39.35%
2006 140.1357 154.5000 204.3000 92.3000 129.1000 -9.15%
2005 78.8363 65.0000 144.9000 49.2000 142.1000 112.09%
2004 54.1374 64.1000 70.0000 35.7000 67.0000 8.06%
2003 69.0024 66.5000 85.4000 61.4900 62.0000 -4.76%
2002 78.8792 121.7000 123.2000 53.6000 65.1000 -45.89%
2001 191.0484 141.3000 354.7000 90.0000 120.3000 -22.39%
2000 305.2417 250.0000 462.5000 140.6000 155.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.965B $0.806B
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their first and only drug approved by any regulatory agency for marketing. BELVIQ was approved by the US Food and Drug Administration, or FDA, for marketing in the United States, and was made available by prescription in June 2013 to adults who are overweight with a comorbidity or obese. They are exploring BELVIQ for possible new indications, using different formulations, and in combination with other drugs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.197B 14.66
Gilead Sciences (GILD) United States $91.996B 11.93
CSL (CSLLY) Australia $87.164B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.883B 50.79
Regeneron Pharmaceuticals (REGN) United States $62.700B 24.17
Illumina (ILMN) United States $52.141B 53.58
Biogen (BIIB) United States $49.695B 8.51
Seattle Genetics (SGEN) United States $26.964B 0.00
Moderna (MRNA) United States $25.614B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.414B 9.63
Incyte (INCY) United States $21.600B 0.00
Genmab (GMAB) Denmark $19.127B 15.75
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Genmab (GNMSF) Denmark $17.896B 53.13
BioMarin Pharmaceutical (BMRN) United States $17.633B 159.85
Alnylam Pharmaceuticals (ALNY) United States $16.134B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.977B 38.43
Exact Sciences (EXAS) United States $12.517B 0.00
BeiGene (BGNE) Cayman Islands $12.307B 0.00
Sarepta Therapeutics (SRPT) United States $11.745B 0.00
BioNTech SE (BNTX) Germany $11.546B 0.00
Bio-Techne Corp (TECH) United States $10.183B 67.27
QIAGEN (QGEN) Netherlands $9.791B 28.47
Horizon Therapeutics Public (HZNP) Ireland $9.455B 23.27
Guardant Health (GH) United States $9.166B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.986B 0.00
Immunomedics (IMMU) United States $7.959B 0.00
Exelixis (EXEL) United States $7.550B 26.47
Repligen (RGEN) United States $7.297B 127.99
Ascendis Pharma (ASND) Denmark $7.032B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.759B 0.00
Reata Pharmaceuticals (RETA) United States $5.318B 0.00
Acceleron Pharma (XLRN) United States $5.307B 0.00
Adaptive Biotechnologies (ADPT) United States $5.295B 0.00
MyoKardia (MYOK) United States $5.018B 0.00
Mirati Therapeutics (MRTX) United States $4.435B 0.00
Emergent Biosolutions (EBS) United States $4.435B 29.07
Ultragenyx Pharmaceutical (RARE) United States $4.403B 0.00
MorphoSys AG (MOR) Germany $4.291B 33.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.268B 93.25
China Biologic Products (CBPO) China $4.239B 23.57
Global Blood Therapeutics (GBT) United States $4.230B 0.00
Vir Biotechnology (VIR) United States $3.972B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.855B 0.00
Bluebird Bio (BLUE) United States $3.716B 0.00
Zai Lab (ZLAB) China $3.690B 0.00
Blueprint Medicines (BPMC) United States $3.532B 0.00
Halozyme Therapeutics (HALO) United States $3.341B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.309B 0.00
Amicus Therapeutics (FOLD) United States $3.267B 0.00
Viela Bio (VIE) United States $3.071B 0.00
NeoGenomics (NEO) United States $2.968B 216.77
UniQure (QURE) Netherlands $2.823B 0.00
Amarin (AMRN) Ireland $2.791B 0.00
Fate Therapeutics (FATE) United States $2.737B 0.00
Denali Therapeutics (DNLI) United States $2.688B 0.00
Alkermes (ALKS) Ireland $2.676B 52.69
Novavax (NVAX) United States $2.672B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.652B 0.00
Alector (ALEC) United States $2.616B 0.00
Insmed (INSM) United States $2.592B 0.00
Inovio Pharmaceuticals (INO) United States $2.226B 0.00
Principia Biopharma (PRNB) United States $2.148B 0.00
Epizyme (EPZM) United States $1.878B 0.00
Ligand Pharmaceuticals (LGND) United States $1.744B 67.90
Eidos Therapeutics (EIDX) United States $1.734B 0.00
Arvinas (ARVN) United States $1.724B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.707B 0.00
Editas Medicine (EDIT) United States $1.655B 0.00
Arcus Biosciences (RCUS) United States $1.648B 0.00
Zymeworks (ZYME) Canada $1.647B 0.00
Adverum Biotechnologies (ADVM) United States $1.644B 0.00
Sangamo Therapeutics (SGMO) United States $1.622B 0.00
REGENXBIO (RGNX) United States $1.618B 0.00
Twist Bioscience (TWST) United States $1.617B 0.00
Intra-Cellular Therapies (ITCI) United States $1.489B 0.00
Akcea Therapeutics (AKCA) United States $1.482B 0.00
Mesoblast (MESO) Australia $1.412B 0.00
PHARMA MAR SA (PHMMF) Spain $1.394B 0.00
NGM Biopharmaceuticals (NGM) United States $1.378B 0.00
Beam Therapeutics (BEAM) United States $1.319B 0.00
Cytokineticsorporated (CYTK) United States $1.303B 0.00
Zealand Pharma (ZEAL) Denmark $1.290B 0.00
I-Mab (IMAB) China $1.215B 0.00
Revance Therapeutics (RVNC) United States $1.212B 0.00
Coherus BioSciences (CHRS) United States $1.212B 8.46
Alcobra (ARCT) United States $1.159B 0.00
Myriad Genetics (MYGN) United States $1.098B 56.65
Intellia Therapeutics (NTLA) United States $1.078B 0.00
Sorrento Therapeutics (SRNE) United States $1.063B 0.00
Compugen (CGEN) Israel $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.939B 0.00
NextCure (NXTC) United States $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.907B 0.00
Cellectis S.A (CLLS) France $0.893B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Cue Biopharma (CUE) United States $0.856B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.773B 0.00
Cara Therapeutics (CARA) United States $0.770B 0.00
Heska (HSKA) United States $0.767B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.751B 0.00
Kadmon Holdings (KDMN) United States $0.746B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.724B 0.00
Retrophin (RTRX) United States $0.719B 0.00
Kala Pharmaceuticals (KALA) United States $0.714B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.700B 0.00
Codexis (CDXS) United States $0.662B 0.00
Castle Biosciences (CSTL) United States $0.653B 0.00
Vericel (VCEL) United States $0.643B 118.83
Morphic Holding (MORF) United States $0.640B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.625B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.620B 5.31
Bellus Health (BLU) Canada $0.620B 0.00
Frequency Therapeutics (FREQ) United States $0.612B 0.00
Athersys (ATHX) United States $0.601B 0.00
Mersana Therapeutics (MRSN) United States $0.584B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.578B 0.00
MeiraGTx Holdings (MGTX) United States $0.576B 0.00
VBI Vaccines (VBIV) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.555B 0.00
NantKwest (NK) United States $0.550B 0.00
AnaptysBio (ANAB) United States $0.542B 0.00
Clovis Oncology (CLVS) United States $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
UROGEN PHARMA (URGN) United States $0.531B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.521B 0.00
AC Immune SA (ACIU) Switzerland $0.503B 0.00
DBV Technologies S.A (DBVT) France $0.494B 0.00
BioDelivery Sciences (BDSI) United States $0.493B 25.97
Aquinox Pharmaceuticals (NLTX) United States $0.493B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Anika Therapeutics (ANIK) United States $0.474B 15.24
Dynavax Technologies (DVAX) United States $0.473B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.464B 0.00
Puma Biotechnology (PBYI) United States $0.461B 0.00
Merus (MRUS) Netherlands $0.440B 0.00
Intrexon (PGEN) United States $0.439B 0.00
Protagonist Therapeutics (PTGX) United States $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.430B 0.00
CytomX Therapeutics (CTMX) United States $0.426B 0.00
MiMedx (MDXG) United States $0.419B 0.00
Agenus (AGEN) United States $0.418B 0.00
Seres Therapeutics (MCRB) United States $0.401B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.396B 0.00
WAVE Life Sciences (WVE) Singapore $0.387B 0.00
PDL BioPharma (PDLI) United States $0.386B 331.00
Albireo Pharma (ALBO) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.382B 7.57
Kamada (KMDA) Israel $0.382B 15.89
Precision BioSciences (DTIL) United States $0.381B 0.00
Geron (GERN) United States $0.369B 0.00
Selecta Biosciences (SELB) United States $0.343B 0.00
MannKind (MNKD) United States $0.320B 0.00
Menlo Therapeutics (MNLO) United States $0.305B 0.00
Verastem (VSTM) United States $0.302B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.272B 0.00
Abeona Therapeutics (ABEO) United States $0.270B 0.00
Starpharma Holdings (SPHRY) Australia $0.268B 0.00
Aduro Biotech (ADRO) United States $0.263B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
Gritstone Oncology (GRTS) United States $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Exicure (XCUR) United States $0.241B 0.00
Liquidia Technologies (LQDA) United States $0.239B 0.00
XOMA (XOMA) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
OSMOTICA PHARM (OSMT) United States $0.230B 0.00
Northwest Biotherapeutics (NWBO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Affimed (AFMD) Germany $0.228B 0.00
HOOKIPA Pharma (HOOK) United States $0.224B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.215B 3.24
IVERIC Bio (ISEE) United States $0.213B 0.00
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
ARAVIVE, INC (ARAV) United States $0.204B 0.00
Kindred Biosciences (KIN) United States $0.201B 0.00
Strongbridge Biopharma (SBBP) United States $0.201B 0.00
Five Prime Therapeutics (FPRX) United States $0.199B 0.00
VTv Therapeutics (VTVT) United States $0.198B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.197B 0.00
Prometic Life Sciences (LMNL) Canada $0.195B 0.00
Aptinyx (APTX) United States $0.192B 0.00
Aytu Bioscience (AYTU) United States $0.182B 0.00
Dyadic (DYAI) United States $0.165B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.161B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.158B 0.00
Biofrontera AG (BFRA) Germany $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Antibe Therapeutics (ATBPF) Canada $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Trevena (TRVN) United States $0.144B 0.00
Cerecor (CERC) United States $0.142B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
AIT Therapeutics (XAIR) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.125B 0.00
Cyclerion Therapeutics (CYCN) United States $0.119B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
Eton Pharmaceuticals (ETON) United States $0.100B 0.00
Organovo Holdings (ONVO) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.091B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.089B 0.00
Celsion (CLSN) United States $0.089B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
Adocia (ADOCY) France $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Oncobiologics (OTLK) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Apricus Biosciences (SEEL) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Advaxis (ADXS) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.036B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
Evogene (EVGN) Israel $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
TrovaGene (CRDF) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00